#high-risk-groups

#high-risk-groups

Prostate cancer screening will not be made routinely available for the vast majority of men across the UK, according to the expected recommendations from a panel of expert government health advisers. The UK national screening committee is expected to only recommend screening for men with the genetic variants BRCA1 and BRCA2 who are between the ages of 45 and 61. Only a few thousand men are expected to be eligible for screening across the UK,